Citi reiterated a Buy rating on Abbott stock while BofA lowered its recommendation, amid tariffs benefiting AI stocks.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citi reiterated a Buy rating on Abbott stock while BofA lowered its recommendation, amid tariffs benefiting AI stocks.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Abbott Laboratories
American global health care and medical device products company